In cervical cancer, some HDAC inhibitors, such as VPA, SAHA, BML-210, and trichostatin A (TSA), significantly inhibit tumor growth when combined with DNA-demethylating agents, proteosome inhibitors, or cisplatin. The gene discussed is HDAC9; the disease is neoplasm.